Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study

Chin Med J (Engl). 2021 Jun 24;134(18):2252-2254. doi: 10.1097/CM9.0000000000001565.
No abstract available

Publication types

  • Letter

MeSH terms

  • Autoantibodies*
  • Drugs, Chinese Herbal / therapeutic use*
  • Glomerulonephritis, Membranous* / drug therapy
  • Humans
  • Medicine, Chinese Traditional*
  • Prospective Studies
  • Receptors, Phospholipase A2 / immunology

Substances

  • Autoantibodies
  • Drugs, Chinese Herbal
  • Receptors, Phospholipase A2
  • shenqi